Total Payments
$7,961
2024 Payments
$741.50
Companies
30
Transactions
263
Medicare Patients
7,072
Medicare Billing
$858,286
Payment Breakdown by Category
Food & Beverage$7,457 (93.7%)
Education$504.10 (6.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,457 | 249 | 93.7% |
| Education | $504.10 | 14 | 6.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| CIPLA USA INC. | $2,552 | 6 | $0 (2022) |
| Melinta Therapeutics, LLC | $1,100 | 60 | $0 (2024) |
| Insmed, Inc. | $907.02 | 42 | $0 (2024) |
| Merck Sharp & Dohme LLC | $689.14 | 35 | $0 (2024) |
| Astellas Pharma US Inc | $390.36 | 12 | $0 (2024) |
| The Medicines Company | $249.20 | 10 | $0 (2017) |
| Paratek Pharmaceuticals, Inc. | $226.38 | 12 | $0 (2024) |
| La Jolla Pharmaceutical Company | $187.75 | 10 | $0 (2024) |
| Gilead Sciences, Inc. | $180.05 | 4 | $0 (2023) |
| Janssen Biotech, Inc. | $163.41 | 16 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $741.50 | 23 | Insmed, Inc. ($160.86) |
| 2023 | $535.70 | 24 | Insmed, Inc. ($160.61) |
| 2022 | $2,505 | 48 | CIPLA USA INC. ($1,658) |
| 2021 | $1,434 | 31 | CIPLA USA INC. ($893.99) |
| 2020 | $370.55 | 24 | Insmed, Inc. ($159.70) |
| 2019 | $1,027 | 52 | Melinta Therapeutics, Inc. ($180.47) |
| 2018 | $485.27 | 28 | Melinta Therapeutics, Inc. ($211.72) |
| 2017 | $862.14 | 33 | The Medicines Company ($249.20) |
All Payment Transactions
263 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | Astellas Pharma US Inc | Cresemba (Drug) | Food and Beverage | In-kind items and services | $34.53 | General |
| Category: Infectious Diseases | ||||||
| 12/02/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: Respiratory | ||||||
| 11/04/2024 | Merck Sharp & Dohme LLC | PREVYMIS (Drug), ZERBAXA, DIFICID | Food and Beverage | In-kind items and services | $20.36 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/29/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $24.59 | General |
| Category: ANTIBIOTIC | ||||||
| 10/21/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $20.14 | General |
| Category: Respiratory | ||||||
| 10/14/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug), ZERBAXA | Food and Beverage | In-kind items and services | $23.11 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/24/2024 | La Jolla Pharmaceutical Company | XERAVA (Drug) | Food and Beverage | In-kind items and services | $26.35 | General |
| Category: TETRACYCLINE CLASS ANTIBACTERIAL | ||||||
| 09/23/2024 | Merck Sharp & Dohme LLC | PREVYMIS (Drug), ZERBAXA, DIFICID | Food and Beverage | In-kind items and services | $26.94 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 08/26/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: Respiratory | ||||||
| 08/20/2024 | MIMEDX Group, Inc. | — | Food and Beverage | In-kind items and services | $139.70 | General |
| 08/12/2024 | Urgo Medical North America, LLC | URGOK2 (Device) | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: COMPRESSION | ||||||
| 07/23/2024 | Smith+Nephew, Inc. | GRAFIX PL (Medical Supply) | Food and Beverage | In-kind items and services | $103.37 | General |
| Category: Other Advanced Wound Management | ||||||
| 06/25/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $21.79 | General |
| Category: Respiratory | ||||||
| 05/16/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $22.52 | General |
| Category: Respiratory | ||||||
| 05/01/2024 | Takeda Pharmaceuticals U.S.A., Inc. | LIVTENCITY (Drug) | Food and Beverage | In-kind items and services | $44.62 | General |
| Category: IMMUNOLOGY | ||||||
| 04/29/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $23.08 | General |
| Category: Respiratory | ||||||
| 04/17/2024 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: Infections and Infectious Diseases | ||||||
| 03/27/2024 | Melinta Therapeutics, LLC | Rezzayo (Drug), Kimyrsa | Food and Beverage | In-kind items and services | $24.87 | General |
| Category: ANTIFUNGALS | ||||||
| 03/25/2024 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $22.71 | General |
| Category: Infections and Infectious Diseases | ||||||
| 02/06/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: Respiratory | ||||||
| 01/30/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug), RECARBRIO, ZERBAXA | Food and Beverage | In-kind items and services | $32.86 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 01/18/2024 | AIMMUNE THERAPEUTICS, INC. | VOWST (Biological) | Food and Beverage | In-kind items and services | $24.43 | General |
| Category: GI | ||||||
| 01/08/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: Respiratory | ||||||
| 11/06/2023 | La Jolla Pharmaceutical Company | XERAVA (Drug) | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: TETRACYCLINE CLASS ANTIBACTERIAL | ||||||
| 10/30/2023 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $21.64 | General |
| Category: Infections and Infectious Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 1,623 | 2,909 | $728,625 | $212,309 |
| 2022 | 9 | 1,754 | 2,935 | $698,330 | $199,534 |
| 2021 | 11 | 1,681 | 3,117 | $711,495 | $209,396 |
| 2020 | 13 | 2,014 | 3,536 | $822,936 | $237,047 |
Total Patients
7,072
Total Services
12,497
Medicare Billing
$858,286
Procedure Codes
43
All Medicare Procedures & Services
43 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 637 | 1,456 | $364,000 | $89,718 | 24.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 432 | 449 | $123,500 | $44,221 | 35.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 151 | 433 | $151,550 | $40,634 | 26.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 111 | 206 | $20,600 | $14,000 | 68.0% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 168 | 187 | $28,050 | $7,232 | 25.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 39 | 60 | $9,000 | $5,624 | 62.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 39 | 40 | $16,000 | $5,376 | 33.6% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Facility | 2023 | 16 | 20 | $4,000 | $2,096 | 52.4% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 15 | 43 | $9,675 | $2,089 | 21.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 15 | 15 | $2,250 | $1,320 | 58.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 633 | 1,436 | $359,000 | $80,561 | 22.4% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 483 | 510 | $140,300 | $53,420 | 38.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 144 | 318 | $111,300 | $26,111 | 23.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 126 | 242 | $24,200 | $15,707 | 64.9% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 192 | 202 | $30,300 | $6,213 | 20.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 34 | 35 | $13,950 | $5,442 | 39.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 43 | 53 | $7,950 | $4,941 | 62.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 72 | 112 | $7,280 | $4,916 | 67.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 27 | 27 | $4,050 | $2,223 | 54.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 608 | 1,342 | $335,500 | $78,078 | 23.3% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 428 | 450 | $123,775 | $49,117 | 39.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 169 | 394 | $137,900 | $32,891 | 23.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 112 | 214 | $21,400 | $15,073 | 70.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 75 | 136 | $20,400 | $13,704 | 67.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 45 | 45 | $18,000 | $7,323 | 40.7% |
About Dr. Javier Marinez, MD
Dr. Javier Marinez, MD is a Infectious Disease healthcare provider based in Altamonte Springs, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/10/2007. The National Provider Identifier (NPI) number assigned to this provider is 1679696983.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Javier Marinez, MD has received a total of $7,961 in payments from pharmaceutical and medical device companies, with $741.50 received in 2024. These payments were reported across 263 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($7,457).
As a Medicare-enrolled provider, Marinez has provided services to 7,072 Medicare beneficiaries, totaling 12,497 services with total Medicare billing of $858,286. Data is available for 4 years (2020–2023), covering 43 distinct procedure/service records.
Ad
Practice Information
- Specialty Infectious Disease
- Location Altamonte Springs, FL
- Active Since 04/10/2007
- Last Updated 07/25/2012
- Taxonomy Code 207RI0200X
- Entity Type Individual
- NPI Number 1679696983
Products in Payments
- ZEMDRI (PLAZOMICIN) (Drug) $1,658
- Arikayce (Drug) $885.74
- Vabomere (Drug) $539.75
- DIFICID (Drug) $317.72
- ZERBAXA (Drug) $289.63
- Kimyrsa (Drug) $277.17
- NUZYRA (Drug) $226.38
- Baxdela (Drug) $213.50
- XERAVA (Drug) $187.75
- ORBACTIV (Drug) $180.71
- Symtuza (Drug) $150.47
- TYRX (Device) $125.00
- Biktarvy (Drug) $124.73
- AVYCAZ (Drug) $123.99
- Fetroja (Drug) $122.75
- Cresemba (Drug) $105.59
- LIVTENCITY (Drug) $103.66
- GRAFIX PL (Medical Supply) $103.37
- CRESEMBA (Drug) $94.26
- VIBATIV (Drug) $87.59
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Altamonte Springs
Dr. Juan Diaz, D.o, D.O
Infectious Disease — Payments: $1.1M
Infectious Disease $1.1M
Jason Sniffen, Do, DO
Infectious Disease — Payments: $459,299
Infectious Disease $459,299
Christopher Cooper, Md, MD
Infectious Disease — Payments: $373,256
Infectious Disease $373,256
Fernando Alvarado, Md, MD
Infectious Disease — Payments: $16,125
Infectious Disease $16,125
Dr. Anibal Maldonado, M.d, M.D
Infectious Disease — Payments: $4,049
Infectious Disease $4,049
Joseph Katta, Do, DO
Infectious Disease — Payments: $2,143
Infectious Disease $2,143